Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Hospitalized cirrhotic patients are at high risk of complications and adverse outcomes. This study aims to determine the current practice and outcomes in these following areas:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Frequency, Cause and Outcome of Community-acquired infections | Collecting details of infections including type, organism, antibiotic used, length of stay, ICU stay and outcomes | From admission to 1 year post-discharge from the hospital |
| Frequency, Cause, and Outcome of Nosocomial infections | Collecting details of infections including type, organism, antibiotic used, length of stay, ICU stay and outcomes | From admission to 1 year post-discharge from the hospital |
| Development of second infections | Distinctly different from primary infection | From admission to 1 year post-discharge from the hospital |
| Factors predicting ICU care, organ failure, death, and disability | Admission to the ICU and events/outcomes of that subject's admission | From admission to 1 year post-discharge from the hospital |
| Patterns and adequacy of albumin use in infected and non-infected patients | IV albumin administration | From admission to 1 year post-discharge from the hospital |
| Quality-assurance and adequacy of management of complications of cirrhosis such as hepatic encephalopathy, variceal bleeding, hyponatremia, and hypernatremia | Blood test and other obvious clinical evidence of decompensation | From admission to 1 year post-discharge from the hospital |
| Peri and post-liver transplant outcomes based on physiological parameters |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Hospitalized cirrhotic patients
Not provided
| ID | Term |
|---|---|
| D005355 | Fibrosis |
| ID | Term |
|---|---|
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
Not provided
Not provided
Not provided
Collection of liver transplant donor and recipient information such as blood group, CMV status, post-transplant infections, immunosuppression regimen, and prophylaxis given. |
| From admission to 1 year post-discharge from the hospital |
| Regional variations in outcomes and therapeutic strategies | Comparison of data between sites conducting this study across the United States and Canada | From admission to 1 year post-discharge from the hospital |